N E Babady1, A Aslam2, T McMillen1, M Syed3, A Zehir3, M Kamboj4. 1. Clinical Microbiology Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 2. Infection Control and Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 4. Infection Control and Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: Kambojm@mskcc.org.
Abstract
BACKGROUND: Cases of Clostridiodes difficile infection (CDI) diagnosed after hospital discharge account for a substantial proportion of new infections. It is unclear whether post-discharge infections originate from hospital-based transmission. METHODS: This was a Retrospective cohort study at a tertiary-care cancer center (non-outbreak setting). For all laboratory-identified cases of CDI in 2015-2016, patients with post-discharge (PD) CDI within eight weeks of their hospital stay were included in the study. Isolates from PD-CDI cases and their CDI-positive unit-based contacts were first genotyped by multilocus sequence typing (MLST). Common strains were further examined by core genome sequencing (CGS) to evaluate transmission links. RESULTS: Of 173 cases examined by MLST, 50% of PD cases matched previous unit contacts. Next, 34 isolates, including 16 PD cases and their 18-unit contacts were examined by CGS. None were ≤3 single-nucleotide variants apart. Seventy percent of PD cases had in-hospital antibiotic exposure before CDI onset in the community. CONCLUSION: Our study results suggest that symptomatic CDI cases are not a substantial source of transmission to PD cases. Frequent antibiotic exposure in post-discharge CDI cases is an important target for surveillance and stewardship efforts.
BACKGROUND: Cases of Clostridiodes difficile infection (CDI) diagnosed after hospital discharge account for a substantial proportion of new infections. It is unclear whether post-discharge infections originate from hospital-based transmission. METHODS: This was a Retrospective cohort study at a tertiary-care cancer center (non-outbreak setting). For all laboratory-identified cases of CDI in 2015-2016, patients with post-discharge (PD) CDI within eight weeks of their hospital stay were included in the study. Isolates from PD-CDI cases and their CDI-positive unit-based contacts were first genotyped by multilocus sequence typing (MLST). Common strains were further examined by core genome sequencing (CGS) to evaluate transmission links. RESULTS: Of 173 cases examined by MLST, 50% of PD cases matched previous unit contacts. Next, 34 isolates, including 16 PD cases and their 18-unit contacts were examined by CGS. None were ≤3 single-nucleotide variants apart. Seventy percent of PD cases had in-hospital antibiotic exposure before CDI onset in the community. CONCLUSION: Our study results suggest that symptomatic CDI cases are not a substantial source of transmission to PD cases. Frequent antibiotic exposure in post-discharge CDI cases is an important target for surveillance and stewardship efforts.
Authors: Mini Kamboj; Anna Sheahan; Janet Sun; Ying Taur; Elizabeth Robilotti; Esther Babady; Genovefa Papanicolaou; Ann Jakubowski; Eric Pamer; Kent Sepkowitz Journal: Infect Control Hosp Epidemiol Date: 2015-10-21 Impact factor: 3.254
Authors: Carlene A Muto; Marian Pokrywka; Kathleen Shutt; Aaron B Mendelsohn; Kathy Nouri; Kathy Posey; Terri Roberts; Karen Croyle; Sharon Krystofiak; Sujata Patel-Brown; A William Pasculle; David L Paterson; Melissa Saul; Lee H Harrison Journal: Infect Control Hosp Epidemiol Date: 2005-03 Impact factor: 3.254
Authors: Sahil Khanna; Darrell S Pardi; Scott L Aronson; Patricia P Kammer; Robert Orenstein; Jennifer L St Sauver; W Scott Harmsen; Alan R Zinsmeister Journal: Am J Gastroenterol Date: 2011-11-22 Impact factor: 10.864
Authors: Larry K Kociolek; Dale N Gerding; Robyn O Espinosa; Sameer J Patel; Stanford T Shulman; Egon A Ozer Journal: Clin Infect Dis Date: 2018-07-02 Impact factor: 9.079
Authors: David Griffiths; Warren Fawley; Melina Kachrimanidou; Rory Bowden; Derrick W Crook; Rowena Fung; Tanya Golubchik; Rosalind M Harding; Katie J M Jeffery; Keith A Jolley; Richard Kirton; Tim E Peto; Gareth Rees; Nicole Stoesser; Alison Vaughan; A Sarah Walker; Bernadette C Young; Mark Wilcox; Kate E Dingle Journal: J Clin Microbiol Date: 2009-12-30 Impact factor: 5.948
Authors: Maria C Mora Pinzon; Ronald Buie; Jinn-Ing Liou; Daniel K Shirley; Charlesnika T Evans; Swetha Ramanathan; Linda Poggensee; Nasia Safdar Journal: Clin Infect Dis Date: 2019-04-08 Impact factor: 9.079
Authors: Ling Yuan Kong; David W Eyre; Jacques Corbeil; Frederic Raymond; A Sarah Walker; Mark H Wilcox; Derrick W Crook; Sophie Michaud; Baldwin Toye; Eric Frost; Nandini Dendukuri; Ian Schiller; Anne-Marie Bourgault; Andrew Dascal; Matthew Oughton; Yves Longtin; Louise Poirier; Paul Brassard; Nathalie Turgeon; Rodica Gilca; Vivian G Loo Journal: Clin Infect Dis Date: 2019-01-07 Impact factor: 9.079
Authors: Jessica S H Martin; David W Eyre; Warren N Fawley; David Griffiths; Kerrie Davies; Damian P C Mawer; Timothy E A Peto; Derrick W Crook; A Sarah Walker; Mark H Wilcox Journal: Clin Infect Dis Date: 2018-10-15 Impact factor: 9.079